+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
JUBLINGREA

Jubilant Ingrevia Share Price

 
37.13% Gain from 52W Low

 

Jubilant Ingrevia live price: ₹736.80. It opened at ₹747 vs previous close ₹744; intraday high/low: ₹747/₹734. The 50 & 200 DMA stand at ₹690.50/₹674.70.

Jubilant Ingrevia Performance

  • Today's Low
  • ₹734
  • Today's High
  • ₹747
  • 52 Week Low
  • ₹537
  • 52 Week High
  • ₹846
  • Open Price₹747
  • Previous Close₹744
  • Volume62,822
  • 50 DMA₹690.50
  • 100 DMA₹677.00
  • 200 DMA₹674.70

Jubilant Ingrevia Chart

Investment Returns

  • Over 1 Month + 18.52%
  • Over 3 Month + 0.3%
  • Over 6 Month + 18.53%
  • Over 1 Year -5.5%

Smart Investing Starts Here Start SIP with Jubilant Ingrevia for Steady Growth!

Invest Now

Jubilant Ingrevia Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38
  • PEG Ratio
  • 3.4
  • Market Cap Cr
  • 11,736
  • P/B Ratio
  • 3.8
  • Average True Range
  • 28.2
  • EPS
  • 19.4
  • Dividend Yield
  • 0.7
  • MACD Signal
  • 22.7
  • RSI
  • 60.3
  • MFI
  • 34.24

Latest Stock News Updates

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Investors'' Conference Call for the Quarter ended June 30, 2026

Jubilant Ingrevia plans 600 crore annual capex, weighs $500-million-plus acquisitions

Jubilant Ingrevia expanding its six-plant Indian manufacturing network after Q1 FY27 revenue rose 25 per cent to 1,300 crore on stronger demand for nutrition, personal care and specialty chemical products

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Submission of unaudited Standalone and consolidated financial results for quarter ending June 30, 2026

Jubilant Ingrevia Financials

Jubilant Ingrevia Technicals

EMA & SMA

Current Price
₹736.80
-7.3 (-0.98%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹716.60
  • 50 Day
  • ₹690.50
  • 100 Day
  • ₹677.00
  • 200 Day
  • ₹674.70

Resistance and Support

739.53 Pivot Speed
  • R3 787.80
  • R2 771.50
  • R1 757.80
  • S1 727.80
  • S2 711.60
  • S3 697.90

Jubilant Ingrevia Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-22 Quarterly Results
2026-05-26 Audited Results & Final Dividend
2026-02-04 Quarterly Results
2025-10-27 Quarterly Results
2025-07-31 Quarterly Results
Date Purpose Remarks
2026-07-24 FINAL Rs.2.50 per share(250%)Final Dividend
2026-02-10 INTERIM Rs.2.50 per share(250%)Interim Dividend
2025-07-25 FINAL Rs.2.50 per share(250%)Final Dividend
2025-02-03 INTERIM Rs.2.50 per share(250%)Interim Dividend
2024-08-02 FINAL Rs.2.50 per share(250%)Final Dividend
View Jubilant Ingrevia Dividend History Arrow

Jubilant Ingrevia Shareholding Pattern

45.22%
22.39%
22.3%
6.49%
2.61%

About Jubilant Ingrevia

Jubilant Ingrevia The Group is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, View More
  • NSE Symbol
  • JUBLINGREA
  • BSE Symbol
  • 543271
  • Executive Director,Managing Director,Chief Executive Officer
  • Mr. Deepak Jain
  • ISIN
  • INE0BY001018

Similar Stocks to Jubilant Ingrevia

Jubilant Ingrevia FAQs

Jubilant Ingrevia share price is ₹736 As on 28 July, 2026 | 10:48

The Market Cap of Jubilant Ingrevia is ₹11735.8 Cr As on 28 July, 2026 | 10:48

The P/E ratio of Jubilant Ingrevia is 38 As on 28 July, 2026 | 10:48

The PB ratio of Jubilant Ingrevia is 3.8 As on 28 July, 2026 | 10:48

The 52 week High & Low of Jubilant Ingrevia is ₹845.6/₹537.3 respectively As on 28 July, 2026 | 10:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23